CTG was named by the State University of New York at Buffalo (UB) as one of the companies that will gain access to its Center for Computational Research (CCR), which houses UB's supercomputing resources including one of the world's largest, most powerful supercomputers.  CTG will become a key user of the CCR as part of one of several UB initiatives to be funded by investments recently announced by Governor Cuomo to establish New York State as a national leader in genomic medicine and to advance new ways to treat, prevent and manage serious diseases.  These investments will leverage UB's significant expertise in genomics, medical research, and the analysis of patient data with the capabilities of UB's research centers housed within its Center for Computational Research, New York Center of Excellence in Bioinformatics and Life Sciences, and Institute for Health Informatics.  CTG has previously provided IT services to UB and affiliated organizations for big data medical informatics projects.

James R. Boldt, CTG chairman and chief executive officer commented, "Access to the CCR's supercomputers and the big data infrastructure for electronic medical records and claims data to be built by UB will help CTG to enhance our clinical decision support application for better managing chronic kidney disease and to expand it to other diseases.  Based upon CTG's experience and expertise in big data analytics for healthcare, we also anticipate introducing an offering that would enable firms to perform data analytics using the CCR supercomputers and big data infrastructure.  Our relationship with UB's CCR will differentiate CTG as we deliver new medical informatics products and services and help position us as an important emerging big data analytics company targeted to healthcare."